Regulatory Updates: Page 56

FDA advisers consider time limit for bone drugs
By Reuters Health
ADELPHI, Md. (Reuters) - U.S. health advisers are considering a time limit for taking a class of drugs used by millions of women to prevent bone fractures, due to concerns over unusual fractures linked to the medicines and possible higher cancer rates.
September 8, 2011
2009 07 28 13 33 39 581 Fda Logo 70
FDA panels want revised labels on bisphosphonate drugs
By DrBicuspid.com staff writers
Manufacturers of bisphosphonate drugs such as Fosamax and Zometa should make changes to their product labeling to reduce the risk of bone fractures, two U.S. Food and Drug Administration (FDA) advisory panels concluded Friday.
September 8, 2011
J&J to modify some toothbrush whitening claims
By DrBicuspid.com staff writers
The National Advertising Division of the Council of Better Business Bureaus has recommended that Johnson & Johnson Healthcare Products modify certain claims for its Reach Total Care + Whitening toothbrush to clarify that the brush whitens teeth through the abrasive action rather than through bleaching.
September 8, 2011
Ga. dental board mulls direct supervision of hygienists
By Donna Domino
The Georgia Board of Dentistry wants to adopt a proposal requiring that hygienists who provide basic preventive dental services in schools, community health centers, and prisons must now be under the direct supervision of a dentist. Critics call the change an unnecessary obstacle for access to care, especially for children.
September 7, 2011
2009 10 28 09 40 23 4 Woman Dentist 70 V2
Mass. dentist disciplined for administering Botox
By Donna Domino
A well-known Massachusetts dentist who was disciplined for unauthorized use of Botox and inadequate sterilization procedures is a compelling reminder that dental practitioners need to keep abreast of state and federal regulatory changes that affect their practices.
September 6, 2011
2008 08 29 15 39 44 564 Justice Scale 70
FDA panels to review bisphosphonate risks
By DrBicuspid.com staff writers
Two U.S. Food and Drug Administration (FDA) advisory panels will meet this week to review the potential risks associated with long-term use of bisphosphonate medications such as Fosamax and to determine whether these drugs are safe and effective when used longer than three to five years, according to a story in the New York Times.
September 5, 2011
SafeLink offers online quality/infection control management
By DrBicuspid.com staff writers
SafeLink Consulting's new UQ System is a cloud-based application that helps dental labs and dental practices implement and manage quality systems and safety programs online.
September 1, 2011
European group issues dental CBCT guidelines
By DrBicuspid.com staff writers
A European consortium has developed comprehensive guidelines for the appropriate use of cone-beam CT (CBCT) in dentistry, including referral criteria, radiation protection of patients and staff, training, and quality assurance procedures.
September 1, 2011
Ore. dental board says 'no' to Groupon
By DrBicuspid.com staff writers
Daily deal coupons such as those sold by Groupon and Living Social violate the Oregon Board of Dentistry's "unprofessional conduct" rule, the board determined at its August 19 meeting.
September 1, 2011
Biolase gets Canadian approval for Waterlase iPlus
By DrBicuspid.com staff writers
Biolase Technology has received approval from the Medical Devices Bureau of Health Canada to sell its Waterlase iPlus all-tissue dental laser systems in Canada.
August 28, 2011
New infection-control rules take effect in Calif.
By Kathy Kincade
Dental professionals in California, take note: New infection-control regulations announced by the Dental Board of California took effect August 20. And some dental team members may not be too happy with the changes.
August 21, 2011
2011 07 08 15 53 34 250 Glove Hand 70
Dentsply/Astra Tech deal to close Aug. 31
By DrBicuspid.com staff writers
Dentsply International has received regulatory approval from the relevant national competition authorities to proceed with the acquisition of Astra Tech, a provider of dental implant and urology products, from AstraZeneca.
August 18, 2011
Previous Page
Page 56 of 73
Next Page